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Background. To overcome the relatively low accuracy of exercise stress testing (EST) in 
detecting coronary artery disease (CAD), both echocardiography and perfusion scintigraphy 
have been evaluated in conjunction with pharmacologic stress, but there is still uncertainty of 
the relative value of these tests as possible first-line examinations for suspected CAD. This study 
evaluated the accuracy of EST, dipyridamole and dobutamine stress echocardiography (DIP- 
ECHO, DOB-ECHO), and dipyridamole and dobutamine technetium 99m sestamibi tomogra- 
phy (DIP-MIBI, DOB-MIBI) for the detection of CAD in patients evaluated for the first time 
because of chest pain. 
Methods and results. Sixty patients underwent EST, DIP-ECHO, DOB-ECHO, DIP-MIBI, 
and DOB-MIBI. Echocardiographic images were acquired simultaneously with sestamibi 
injections, and the scintigraphic images were collected 1 hour later. Coronary angiography was 
performed within 15 days. Out of 33 patients with significant (>70%) coronary stenoses, 19 
(58%) were correctly identified by EST, 18 (55%) by DIP-ECHO, 20 (61%) by DOB-ECHO, 32 
(97%) by DIP-MIBI, and 30 (91%) by DOB-MIBI (p < 0.005 for MIBI vs EST and ECHO). The 
specificity of EST was 67% (p < 0.05 vs ECHO and MIBI), 96%, 96%, 89%, and 81%, 
respectively. Of the 62 stenotic coronary arteries, 20 (32%) were correctly identified by 
DIP-ECHO, 24 (39%) by DOB-ECHO, 48 (77%) by DIP-MIBI, and 45 (73%) by DOB-MIBI. 
The sensitivity of the imaging techniques in predicting the presence of multivessel disease was 
14% and 29% for DIP and DOB-ECHO compared with 48% and 57% for DIP and DOB-MIBI. 
Conclusions. Our results confirm the limited reliability of EST in detecting CAD and the 
good diagnostic value of DIP and DOB-MIBI. Conversely, the lower sensitivity and the poorer 
capability to recognize multivessel CAD do not support the role of either DIP or DOB-ECHO 
as first-line examination for suspected CAD. (J Nucl Cardiol 1998;5:19-27.) 
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Pharmacologic stress testing is usually associated 
with imaging techniques. Both echocardiography and 
perfusion scintigraphy with thallium-201 have been per- 
formed in conjunction with dipyridamole or dobutamine 
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infusion and have been shown to be reliable for detecting 
coronary artery disease (CAD). '-'8 More recently tech- 
netium 99m-labeled perfusion agents such as technetium 
99m sestamibi have been introduced.'9.2~ Because of the 
absence of significant redistribution, technetium 99m 
sestamibi may be injected during stress echocardiogra- 
phy, and the scintigraphy acquisition may be delayed. 
Therefore it is possible to compare directly the results of 
echocardiography and perfusion scintigraphy in combi- 
nation with a single stress test. 
So far, the diagnostic accuracy of stress echocardi- 
ography and stress scintigraphy has been mainly evalu- 
ated in patient populations with high pretest probability 
of disease or with known CAD. Only limited data 
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concerning the reliabil i ty of  these tests in an unselected 
population of  patients without a history of  CAD who 
seek medical  counseling for the first t ime because of  
chest  pain are available. 2"23 It is still uncertain what the 
relative value of  these tests is as a possible first-line 
examination for suspected CAD. 
We therefore prospectively performed a head-to- 
head comparison of  the diagnostic accuracy of  exercise 
stress testing (EST), dipyr idamole and dobutamine echo- 
cardiography (DIP-ECHO, DOB-ECHO),  and dipyrid- 
amole and dobutamine technetium 99m sestamibi to- 
mography (DIP-MIBI,  DOB-MIBI)  in a group of  
patients who were examined for the first time because of  
chest pain and who had no history of  previous clinical 
manifestations of  CAD. 
METHODS 
Patient Population 
Among the patients referred to the Division of Cardiology 
of Careggi Hospital for evaluation of chest pain of suspected 
coronary cause, 60 patients were prospectively enrolled for the 
study. Chest pain was typical for angina pectoris in 10 (17%) 
patients and atypical in 50. Patients with documented CAD, 
known angina pectoris, previous myocardial infarction, or other 
cardiac disease including rhythm disturbances, valvular heart 
disease, and cardiomyopathy were excluded; patients with 
abnormal baseline electrocardiograms (such as those with 
nonisoelectric rest ST segment), abnormal baseline echocardio- 
grams (such as those with left ventricular hypertrophy or 
segmental wall motion abnormalities), inability to exercise 
adequately, contraindications to exercise or dipyridamole or 
dobutamine administration, and poor acoustic window were 
also excluded. 
The pretest likelihood of CAD. expressed as mean --- 
standard error of percentage, was calculated with the use of 
probability analysis based on age, sex, and symptoms. 24 Thirty- 
two patients had intermediate (20% to 80%) pretest probability, 
whereas 18 had low (<20%) and 10 had high (>80%) pretest 
probability of CAD. 
Study Protocol 
All patients underwent EST, DIP-ECHO and DOB- 
ECHO, DIP-MIBI and DOB-MIBI, resting technetium 99m 
sestamibi tomography, and coronary angiography. EST was 
usually the first test performed. Dipyridamole and dobutamine 
stresses were performed in random order on the following 2 
days. Echocardiographic images were continuously acquired 
throughout the test. The images at peak stress were acquired 
simultaneously with technetium 99m sestamibi injection, and 
the scintigraphic images were collected approximately 1 hour 
later. On the fourth day resting technetium 99m sestamibi 
tomography was performed. Coronary angiography was per- 
formed according to the study protocol within 15 days of 
exercise testing. At the time of the entry in the study no patient 
was receiving cardioactive drugs or drugs containing xanthine. 
The clinical conditions of all patients remained stable for the 
whole study. 
The study protocol was approved by the local Ethics 
Committee on Human Research. All patients gave informed 
consent to participate in the study. 
Exercise Stress Testing 
All patients underwent a symptom-limited upright bicycle 
exercise test with a stepwise increment of 30 W every 3 
minutes. Twelve-lead electrocardiography and arterial blood 
pressure were continuously monitored and recorded at baseline 
and at 1-minute intervals during exercise and recovery. The ST 
segment level was calculated by averaging the signal with a 
computer-assisted system (Marquette Case 21) and was visu- 
ally reviewed by an experienced observer. End points of the test 
were severe chest pain, ischemic ST-depression (horizontal or 
downsloping ST segment -->0.1 mV at 80 msec after the J 
point), fatigue, hypertensive response (systolic blood pressure 
of >230 mm Hg, diastolic blood pressure >120 mm Hg), 
hypotension (pressure drop >20 mm Hg), or maximal pre- 
dicted heart rate in the absence of other criteria for interrupting 
the test. An ischemic response was defined as a 0.1 mV 
horizontal or downsioping ST segment depression persisting 80 
msec after the J point. The presence and nature of limiting 
symptoms were recorded. 
Dipyrldamole Test 
Patients were instructed to avoid beverages containing 
xanthine for at least 12 hours before the test. Dipyridamole was 
infused in a dose of 0.56 mg/kg over a 4-minute period 
followed by a 4-minute interval and then by a second dose of 
0.28 mg/Kg over a 2-minute period. Thus the cumulative dose 
was 0.84 mg/kg over a 10-minute period. Infusion was inter- 
rupted at achievement of peak dose, at onset of ischemia 
(indicated by chest pain associated with horizontal or 
downsloping ST segment depression 0.1 mV at 80 msec after 
the J point or development of wall motion abnormalities), or at 
the occurrence of remarkable side effects (dyspnea, ventricular 
arrhythmias, systolic blood pressure drop >20 mm Hg). 
Twelve-lead electrocardiography and arterial blood pressure 
were recorded at baseline and at l-minute intervals during the 
infusion and in the 10 minutes after the end of dipyridamole 
administration. Echocardiography was performed at baseline 
and continuously throughout drug infusion and up to 8 minutes 
after the end of dipyridamole administration. Technetium 99m 
sestamibi (740 MBq, 20 mCi) was injected 2 minutes after the 
completion of the second dose or earlier if ischemia or side 
effects requiring the early termination of the test occurred. 
Aminophylline (120 mg) was routinely administered intrave- 
nously at least 8 minutes after tracer injection. 
Dobutamine Test 
Dobutamine was infused intravenously with a mechanical 
pump at incremental doses of 10, 20, 30, and 40 p.g/kg/min 
every 3 minutes; the maximal rate (40 p.g/kg/min) was main- 
tained for 5 minutes. End points of the test were the achieve- 
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ment of the peak dose, the development of ischemia (as 
previously defined for the dipyridamole test), or the occurrence 
of severe side effects (dyspnea, supraventricular or ventricular 
arrhythmias, systolic blood pressure >230 mm Hg or diastolic 
>120 mm Hg, systolic blood pressure drop >20 mm Hg). 
Atropine (0.5 to 1 mg intravenously) was injected in patients in 
whom at 40 ixm/kg/min the heart rate was persistently <85% 
of the age-predicted maximal value. Twelve-lead electrocardi- 
ography and arterial blood pressure were recorded before the 
infusion was started and at l-minute intervals throughout the 
dobutamine administration and until the heart rate returned to 
< I00 beats/min. Echocardiography was performed at baseline 
and continuously throughout drug infusion and until the heart 
rate returned to <100 beats/min. Technetium 99m sestamibi 
(740 MBq, 20 mCi) was injected after 1 minute of the 
predetermined maximal infusion rate, and the drug infusion 
was subsequently continued for 5 minutes. The tracer injection 
took place earlier in case of the occurrence of one of the criteria 
requiring the premature termination of the test. When atropine 
was used, technetium 99m sestamibi was injected after 3 
minutes. Atenolol (up to 2.5 mg in 5 ml) was available to treat 
side effects, but in no case was the drug used before 8 minutes 
after tracer injection. 
Two-dimensional Echocardlography 
Commercially available equipment (Aloka SSD 870; 2.5 
to 3.5 MHz transducers) was used. The images were recorded 
on VHS videotape. In the baseline and stress studies parastemal 
long- and short-axis and apical four- and two-chamber views 
were obtained. The videotapes were independently analyzed by 
two experienced cardiologists; only the one who performed the 
test had knowledge of the clinical data and of the electrocar- 
diographic response. Both were blind to the angiographic 
results. In case of disagreement the tape was reviewed, and the 
final decision was reached by consensus. The left ventricle was 
divided into 16 segments (at basal and mid-ventricular levels: 
anterior reptal, anterior, lateral, posterolateral, inferior, poste- 
rior septal; at apical level: septal, anterior, lateral, inferior). 
Normal response to stress was defined as the preservation of the 
normal wall motion pattern present at rest or the development 
of homogeneous hyperkinesia. The response to stress was 
considered abnormal when segmental deterioration of thicken- 
ing or wall motion (hypokinesia: reduced thickening and wall 
motion; akinesia: near or total absence of thickening and wall 
motion; dyskinesia: endocardial excursion away from the 
lumen and systolic thinning) developed. The criteria proposed 
by Marwick et al. 23 were used to identify the coronary vessels 
involved. 
Technetium 99m Sestamibi Tomography 
Tomography was collected 60 minutes after technetium 
99m sestamibi injection. An Elscint Apex SP4 gamma camera 
equipped with an ultrahigh resolution collimator with a 20% 
window centered at the 140 keV photopeak of technetium 99m 
was used. Sixty projections of 20 seconds each were acquired 
in step and shoot mode over a 180-degree arc on 64 • 64 
matrixes with a zooming factor of 1.4. The image reconstruc- 
tion was performed with filtered back-projection with a Wiener 
resolution recovery filter. No attenuation or scatter correction 
was used. The transaxial slices were realigned along the heart 
axis, and short-axis, vertical, and horizontal long-axis slices 
were obtained. Each patient study was submitted for evaluation 
to two independent and experienced observers who were 
unaware of any patient data and of the image acquisition 
parameters. Tracer uptake was evaluated with a 4-point scoring 
scheme (from 0 = normal uptake through 3 = absent uptake) 
after the left ventricular wall was divided into 20 segments, 
which were assigned to the three coronary territories as already 
described) 9.25 An uptake score ->2 in at least two segments in 
the baseline single photon emission computed tomography was 
considered indicative of necrosis in that territory. 25 The in- 
crease of the stress uptake score in at least two segments 
compared with the baseline value was regarded as the sign of 
stress-induced hypoperfusion. 2s In case of disagreement the 
data were reviewed, and consensus agreement was reached. 
Coronary Anglo~raphy 
Selective coronary angiography was performed in multi- 
ple views with Judkins or Sones techniques. The degree of 
lumen narrowing was visually estimated with the aid of 
calipers. Stenoses were graded as follows: not significant 
(<70%), moderate (70% to 89%), and severe (>90%). Mul- 
tivessel CAD was recognized when at least two main coronary 
arteries (or their primary branches) were affected by significant 
stenosis. Left main CAD was considered equivalent to two- 
vessel disease with left anterior descending and left circumflex 
artery involvement. The angiographic score according to 
Gensini et al. 26 was calculated for each patient with at least one 
significant stenosis of any of the three main coronary arteries or 
of their primary branches. 
Statistical Analysis 
Continuous variables were expressed as mean value +_ SD 
and were compared with the use of analysis of variance for 
repeated measures with the Tukey test for post hoc comparison. 
Discrete variables were compared with the chi-squared or the 
Fisher exact test depending on sample size. The agreement 
among the different tests was assessed with the k statistic and 
its standard error. The sensitivity, specificity, and positive and 
negative predictive values were calculated in the usual fashion. 
A p value < 0.05 was considered significant. 
RESULTS 
Coronary Angiographic Findings 
Thirty-three (55%) patients had significant CAD: 12 
(36%) single-vessel disease, 13 (40%) two-vessel dis- 
ease, and 8 (24%) three-vessel disease. Two patients had 
left main CAD. Twenty-one stenoses involved the left 
anterior descending artery or its major branches, 16 the 
left circumflex or marginal branches, and 25 the right 
coronary artery. Stenoses were classified as moderate in 
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Table 1. Hemodynamic responses to exercise, 
dipyridamole, and dobutamine stress 
Exercise Dlpyrldamole Dobutamine 
Resting heart rate 71 • 10 7 0 •  
(beats/mln) 
Peak heart rate 135 • 21" 90 _ 12t 
(beats/rain) 
Resting SBP 141 _+ 21 145 +__ 21 
(ram Hg) 
Peak SBP 197 --+ 22~: 132 • 15t 
(rnm Hg) 
Resting RPP I0 • 2.4 I0.1 ___ 2.4 
(X 103) 
Peak RPP 26.6 + 5.4~: I 1.8 • 2.2t 
(X I03) 
69--- 11 
133 --+ 18 
143 - 19 
150 • 19 
10.3 - 2.5 
19.8 • 3.4 
Data are expressed as mean +- SD. 
SBP, systolic blood pressure; RPP, heart-rate x pressure product. 
*p < 0.0005 vs dipyridamole. 
t p  < 0.0005 vs dobutamine. 
~:p < 0.0005 vs dipyridamole and dobutamine. 
23 cases and severe in 39. At least one severe stenosis 
was observed in 16 patients. Twenty-seven patients had 
no significant coronary stenosis. 
Exercise and Pharmacologic Stress 
Hemodynamics and Safety 
The hemodynamic responses to exercise stress test 
and dipyridamole and dobutamine infusions are summa- 
rized in Table 1. The peak rate-pressure product was 
significantly higher during exercise than during dipyrid- 
amole or dobutamine testing; the difference between 
dipyridamole and dobutamine was statistically signifi- 
cant as well. Anginal chest pain occurred in 43% of 
patients during the exercise stress test, in 25% during 
dipyridamole infusion, and in 35% during dobutamine 
infusion (none significant). ST segment depression -->0.1 
mV was recorded in 47%, 25%, and 17% of patients 
during exercise, dipyridamole, and dobutamine testing, 
respectively. In three patients dipyridamole infusion had 
to be terminated prematurely because of severe ischemia. 
No major adverse effects were recorded. Dobutamine 
administration was terminated before peak dose in eight 
patients because of frequent ventricular ectopic beats 
(two cases), ventricular tachycardia (one case), vomiting 
and hypotension (one case), or achievement of the 
maximal heart rate (four cases). In 22 patients atropine 
was injected at dobutamine peak dose to increase heart 
rate; despite atropine, 5 patients did not achieve a heart 
rate >85% of the maximal age-predicted value. 
Reproducibility of Imaging Techniques 
The echocardiographic and scintigraphic images were 
of good quality and could be analyzed in all patients. When 
echocardiographic stress examinations were reviewed, 
there was complete agreement between the two observers in 
110 (92%) of 120 tests, whereas in the remaining I0 studies 
a consensus was reached. Intraobserver variability was 
assessed by one reader; 95% of the tests were reproducibly 
interpreted. Similarly, interobserver and intraobserver 
variability was assessed for technetium 99m sestamibi 
tomography. The two observers agreed in evaluating 
94% of the tests. Intraobserver agreement, evaluated by 
one reader, was 95%. 
Detection of Coronary Artery Disease 
Ischemic ST segment changes during EST occurred 
in 28 patients (19 with CAD and 9 without CAD). An 
abnormal response during DIP-ECHO was detected in 19 
cases (hypokinesia in 6, akinesia in 13); of these, 18 had 
CAD on coronary angiography. DOB-ECHO recognized 
an abnormal response in 21 patients (hypokinesia in 7, 
akinesia in 13, dyskinesia in 1); of these, 20 had CAD. 
Reversible perfusion defects were observed in 35 pa- 
tients with DIP-MIBI; 32 had CAD and 3 no significant 
coronary stenosis. Finally, 35 patients (30 with and 5 
without CAD) showed reversible perfusion defects in 
DOB-MIBI. Sensitivity, specificity, and overall accuracy 
of the five diagnostic methods are reported in Table 2. 
The sensitivities of EST, DIP-ECHO, and DOB-ECHO 
were all significantly lower than those of perfusion 
imaging. The specificity of EST was lower than that of 
the other methods with the exclusion of DOB-MIBI. The 
overall accuracy of EST, DIP-ECHO, and DOB-ECHO 
was similar and significantly lower than that obtained 
with dipyridamole tomography; the accuracy of EST was 
also significantly lower than that of DOB-MIBI. 
Taking into account that dobutamine and dipyrid- 
amole are the two most commonly used pharmacologic 
stressors, respectively, in combination with echocardiog- 
raphy and perfusion tomography, we also evaluated the 
agreement between DOB-ECHO and DIP-MIBI in the 
detection of CAD, which resulted in being only fair, with 
a k value of 0.43 _ 0.1 I. 
Influence of the Extent of Coronary Artery 
Disease 
Figure 1 shows the sensitivity of the five tests in 
patients with one-vessel CAD versus that in patients with 
multivessel CAD. The sensitivity of each stress test in 
patients with multivessel disease exceeded its perfor- 
mance in single-vessel disease, even though these differ- 
ences did not reach statistical significance. 
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Figure 1. Sensitivity of exercise electrocardiography and imaging techniques for diagnosis of 
coronary artery disease in patients with single-vessel (open bars) and multivessei (solid bars) 
disease. EST, Exercise stress testing; DIP-ECHO, dipyridamole echocardiography; DOB-ECHO, 
dobutamine echocardiography; DIP-MIBI, dipyridamole technetium 99m tomography; DOB-MIBI, 
dobutamine technetium 99m tomography. 
Table Z. Results o f  the  d iagnos t i c  tests 
Sensitivity Specificity Overall accuracy 
No points % CI No points % Cl No points % CI 
F.ST 19/33 58 40-75 18/27 67 49-85 37/60 62 49-85 
DIP-ECHO 18/33 55 38-72 26/27 96w 88-100 44/60 73 62-84 
DOB-ECHO 20/33 61 44-79 26/27 96w 88-100 46/60 77 66-88 
DIP-MIBI 32/33 97"t~ 91 - 100 24/27 8911 77-100 56/60 93*82 ~ 86-100 
DOB-MIBI 30/33 91*t~ 81-100 22/27 81 66-96 52/60 87* 78-96 
CI, 95% Confidence intervals. 
"p < 0.005 vs EST. 
t P  < 0.005 vs DIP-ECHO. 
#p < 0.005 vs DOB-ECHO. 
w < 0.01 vs EST. 
lip = 0.05 vs EST. 
82 < 0.03 vs DOB-ECHO. 
Op < 0.01 vs DIP-ECHO. 
"Regarding the influence of stenosis severity, no 
significant difference in sensitivity was observed with 
any of the five diagnostic methods when the patients with 
at least one severe stenosis were compared with the other 
subjects. The trend to higher sensitivity observed with all 
methods appeared more marked for DIP-ECHO (69% in 
patients with severe stenosis vs 41% in those without) 
(Figure 2). 
Taking into account the CAD extent score, a higher 
value was observed in the patients with a true-positive 
response to DIP-ECHO than in those with a false- 
negative test (21.8 vs 16.2, p = 0.16, not significant) and 
in the true-positive cases of DOB-ECHO compared with 
the false-negative responders (23 vs 13.4, p < 0.03). 
A separate aspect relates to the ability of each 
stress-imaging combination to predict the presence of 
multivessel disease as such (by the presence of wall 
motion or perfusion defects in more than one coronary 
territory). In this respect DIP-ECHO and DOB-ECHO 
were less sensitive, predicting 14% and 29% of patients 
with multivessel disease, respectively, compared with 
48% predicted by DOB-MIBI (p < 0.03 vs DIP-ECHO) 
and 57% with DIP-MIBI (p < 0.01 vs DIP-ECHO). 
Specificity was 100% for DIP-ECHO and DOB-ECHO 
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Figure 2. Sensitivity of exercise electrocardiography and imaging techniques for diagnosis of 
coronary artery disease in patient with (closed bars) or without (open bars) at least one coronary 
stenosis >90%. Abbreviations as in Figure 1. 
Table 3. Sens i t iv i ty  o f  the  i m a g i n g  tests in t he  
de tec t i on  o f  i nd iv idua l  vessel  i n v o l v e m e n t  
LAD LCX RCA 
-(.=21)(%) (.=J6)(%) (.=25)(%) 
DIP-ECHO 24 Z5 44 
DOB-ECHO 33 31 48 
DIP-M1Bi 76" 69~ 8482 
DOB-MIBI 71 t" 63w 80"1" 
LAD, Left anterior descending artery; LC.X, left circumflex artery; 
RCA, dght coronary artery. 
*p < 0.01 vs ECHO. 
tP  < 0.03 vs ECHO. 
r < 0.05 vs ECHO. 
w < 0.05 vs DIP-ECHO. 
82 < 0.02 vs ECHO. 
and for DIP-MIBI and 92% for DOB-MIBI (all not 
significant). 
Of the 62 stenotic coronary arteries, 20 (32%) were 
correctly identified by DIP-ECHO, 24 (39%) by DOB- 
ECHO, 48 (77%) by DIP-MIBI (p < 0.00001 vs echo- 
cardiography), and 45 (73%) by DOB-MIBI (p < 0.0005 
vs echocardiography). Table 3 depicts the sensitivity of 
the four imaging methods in the detection of the indi- 
vidual vessel involvement. 
DISCUSSION 
Our results confirm the limited reliability of EST in 
detecting patients with CAD, with sensitivity and spec- 
ificity values in the range of previous studies. 27 
According to other studies ~-5,s-~2.2s DIP-ECHO had a 
sensitivity similar to that of EST and a significantly 
higher specificity. The sensitivity of DIP-MIBI was 
significantly higher than that of DIP-ECHO, whereas the 
specificity was identical. The flow heterogeneity pro- 
duced by dipyridamole does not necessarily imply isch- 
emia in the territories with hypoperfusion. Thus, in 
accordance with the experimental data by Fung et al. 29 
and with the results of other clinical studies, 3~ the 
sensitivity of perfusion imaging was significantly higher 
than that of echocardiography. 
DOB-ECHO had a sensitivity and a specificity 
similar to those of DIP-ECHO; specificity was signifi- 
cantly better compared with that of EST. The sensitivity 
of DOB-MIBI was significantly higher than that of 
DOB-ECHO, whereas the specificity of tomography was 
not significantly lower. No significant difference in 
sensitivity and specificity was observed between dipy- 
ridamole and dobutamine perfusion imaging. 
In previous studies the reported sensitivity of DOB- 
ECHO was higher than that in our  study, 6-12'21-22,32-38 
although an overlap of the confidence intervals can be 
observed. This result may be explained by the different 
patient selection criteria. Several studies included pa- 
tients with ascertained angina or previous myocardial 
infarction or patients who had undergone previous cor- 
onary surgely. 9,11.34,36.38 Even studies excluding patients 
with previous myocardial infarction had patient popula- 
tions that were only apparently similar to ours; only 
patients referred for cardiac catheterization were includ- 
ed. 22"23'34 Typical angina was present in 65% to 77% of 
cases, 23.34 and up to 85% of the patients had been 
receiving antianginal therapy. 22 In our study patients 
referred for first-line evaluation of chest pain were 
enrolled; typical angina was present in only 17% of 
cases, and no patient had had previous antianginal 
therapy. In other studies not all the patients underwent 
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coronary angiographyr; therefore a postreferral bias may 
have been introduced. 
In previous comparative studies the sensitivity of 
DOB-ECHO and perfusion tomography was found to be 
similar, or only a slightly higher sensitivity of perfusion 
imaging was reported. 2j-23.32-35 Our data suggest that 
perfusion heterogeneity and ischemia may be dissociated 
in a significant proportion of patients who undergo 
dobutamine stress testing. This phenomenon occurred in 
30% of our patients. Recently Elhendy et al. 37 reported 
dobutamine-induced hypoperfusion detected by techne- 
tium 99m sestamibi tomography without transient wall 
motion abnormalities at echocardiography in 26% of 
patients. The reduced sensitivity of echocardiography 
compared with that of perfusion imaging has been 
related to a submaximal dobutamine stress test re- 
sponse 37 and milder CAD. 23 In our study a high dose of 
dobutamine combined with additional atropine was used 
to achieve heart rate >85% of the age-predicted maximal 
value; nevertheless, five patients (all with CAD) could 
not reach the target heart rate. Three of these five patients 
had a false-negative DOB-ECHO response, whereas all 
had a true-positive dobutamine tomography response. 
CAD extent and severity have been reported to influence 
the results of DOB-ECHO. 23 This relation has also been 
described with exercise echocardiography. 39 In our study 
the sensitivity of DOB-ECHO increased in patients with 
multivessel disease. False-negative DOB-ECHO results 
correlated with a significantly lower CAD extent score 
compared with patients with true-positive tests. 
Compared with EST, noninvasive imaging tech- 
niques might offer information to predict disease extent 
and severity as well. DIP-MIBI and DOB-MIBI were 
superior to the echocardiographic tests in detecting the 
extent of CAD in terms of one-vessel or multivessel 
involvement, although statistical significance was not 
reached when compared with DOB-ECHO. Dipyridam- 
ole and dobutamine infusions were stopped at the first 
development of wall motion abnormalities; in this setting 
perfusion scintigraphy may have an advantage, because 
flow distribution heterogeneity may precede the devel- 
opment of wall motion abnormalities. Both scintigraphic 
techniques were superior for the correct identification of 
stenotic coronary arteries without a significant difference 
in the involved territories. 
Study  L imi ta t ions  
The number of patients studied was relatively small. 
Stress echocardiography and scintigraphy were used as 
routine diagnostic tools and not for research purposes; 
therefore qualitative evaluation of echocardiographic and 
scintigraphic images was used. The lack of quantitative 
analysis and, for DOB-ECHO, of a computer-assisted 
analysis on a quad screen format could have affected the 
results. However, qualitative evaluation of echocardiog- 
raphy and perfusion scintigraphy is still the routinely 
used method in most clinical laboratories. Regarding the 
second problem, because of the limited availability of 
this technical adjunct, the trend to consider a quad screen 
digital display as mandatory for DOB-ECHO would 
heavily limit the use of this imaging technique in clinical 
practice, particularly in community hospitals, where first- 
line evaluation of suspect chest pain is frequently per- 
formed. The degree of coronary artery stenosis was based 
on a visual estimate. Although this is still the method that is 
routinely used, its limitations are well known. Exercise 
stress perfusion tomography was not included in our pro- 
tocol. It is clear that exercise stress is advantageous 
because it allows us to examine the functional response 
to physical activity. However, in patients who are still 
not recognized as affected by CAD, the importance of 
this information is poorly defined. Finally, prognostic 
information was not considered. The study evaluates 
only the diagnostic application of the  tests; however, 
their relative prognostic strengths may be different. 
Clinical I m p l i c a t i o n s  
Noninvasive diagnostic techniques have large appli- 
cation as screening tests in patients with chest pain. The 
features of the ideal test should be limited cost, wide 
availability, and accuracy. EST is inexpensive and phys- 
iologic, but, as confirmed by our results, it has low 
diagnostic accuracy, and its application in a population 
with generally low to intermediate pretest probability of 
disease is problematic. The diagnostic accuracy of stress 
echocardiography and stress scintigraphy is higher, but 
only the former approach has the cost and availability 
features required for a first-line examination. Unfortu- 
nately, our data suggest that independent of the pharma- 
cologic agent adopted, echocardiography achieves a 
rather modest sensitivity, although its specificity is high. 
Therefore wide use of pharmacologic stress echocardi- 
ography as first-line examination in patients without a 
history of CAD but with suspect chest pain could be 
hazardous. Conversely, perfusion imaging is confirmed 
as highly effective for making the diagnosis of CAD and 
even for obtaining a reliable evaluation of disease extent. 
However, availability and economic problems remain 
major obstacles to its general use. 
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